Scholarlink

Background <p>Despite the quality of life (QoL) and biopsychosocial model gain importance in the management of people living with HIV (PLWH), there is lack of a suitable tool addressing the current demand. This longitudinal methodological study describes the validity, reliability, and responsiveness of the Bilişsel Egzersiz Terapi Yaklaşımı-Biopsychosocial Questionnaire (BETY-BQ), which was previously designed to assess biopsychosocial characteristics, including pain coping skills, functionality, fatigue, emotional state, sleep, sexuality, and sociability, resulting from chronic diseases in PLWH.</p> Methods <p>BETY-BQ was administered to a total of 150 PLWH in the outpatient clinics of two different hospitals. The Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale (HADS), the Clinical Frailty Scale (CFS), and the FRAIL Questionnaire were used for the validity. For both reliability and responsiveness analyses, assessments were conducted in 30 PLWH. Reliability was evaluated by repeating the assessments at 1-week intervals, and responsiveness was assessed by re-administering the same scales at 3-month intervals.</p> Results <p>Moderate to high correlations were found between BETY-BQ and SF-36, HADS, CFS, FRAIL. The correlations between BETY-BQ and SF-36 subheadings ranged from rho=-0.497 to rho=-0.650, <i>p</i> &lt; 0.001, while there were correlations with HADS-Anxiety (rho = 0.717, &lt; 0.001), HADS-Depression (rho = 0.653, &lt; 0.001), CFS (rho = 0.467, &lt; 0.001), FRAIL (rho = 0.559, &lt; 0.001). The score distribution refuted floor and ceiling effects. The reliability of BETY-BQ was confirmed by test-retest strategy (ICC = 0.951). The Cronbach’s α value was 0.943 for the test and 0.963 for the retest. The time-dependent change responsiveness of BETY-BQ was moderately correlated with the depression subheading of the HADS.</p> Conclusions <p>BETY-BQ is as a valid and reliable instrument by which, multidisciplinary-interdisciplinary healthcare teams can evaluate the biopsychosocial features among PLWH in a holistic and practical manner. Preliminary findings also suggest its potential sensitivity to change, particularly concerning depressive symptoms; however, further studies are needed to establish its responsiveness fully.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessing biopsychosocial status in people living with HIV: validity, reliability, and responsiveness of BETY-BQ

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月12日

查看全文
  • Sinan Buran,
  • Orkun Tüfekçi,
  • Erkin Oğuz Sarı,
  • Süreyya Damar-Örenler,
  • Tuba Damar-Çakırca,
  • Ayşen Akgöz,
  • Ayşenur Besler-Tuncer,
  • Yavuz Yakut,
  • Nur Banu Karaca,
  • Mertcan Uzun,
  • Meliha Çağla Sönmezer,
  • Ahmet Çağkan İnkaya,
  • Serhat Ünal,
  • Edibe Ünal

摘要

Background

Despite the quality of life (QoL) and biopsychosocial model gain importance in the management of people living with HIV (PLWH), there is lack of a suitable tool addressing the current demand. This longitudinal methodological study describes the validity, reliability, and responsiveness of the Bilişsel Egzersiz Terapi Yaklaşımı-Biopsychosocial Questionnaire (BETY-BQ), which was previously designed to assess biopsychosocial characteristics, including pain coping skills, functionality, fatigue, emotional state, sleep, sexuality, and sociability, resulting from chronic diseases in PLWH.

Methods

BETY-BQ was administered to a total of 150 PLWH in the outpatient clinics of two different hospitals. The Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale (HADS), the Clinical Frailty Scale (CFS), and the FRAIL Questionnaire were used for the validity. For both reliability and responsiveness analyses, assessments were conducted in 30 PLWH. Reliability was evaluated by repeating the assessments at 1-week intervals, and responsiveness was assessed by re-administering the same scales at 3-month intervals.

Results

Moderate to high correlations were found between BETY-BQ and SF-36, HADS, CFS, FRAIL. The correlations between BETY-BQ and SF-36 subheadings ranged from rho=-0.497 to rho=-0.650, p < 0.001, while there were correlations with HADS-Anxiety (rho = 0.717, < 0.001), HADS-Depression (rho = 0.653, < 0.001), CFS (rho = 0.467, < 0.001), FRAIL (rho = 0.559, < 0.001). The score distribution refuted floor and ceiling effects. The reliability of BETY-BQ was confirmed by test-retest strategy (ICC = 0.951). The Cronbach’s α value was 0.943 for the test and 0.963 for the retest. The time-dependent change responsiveness of BETY-BQ was moderately correlated with the depression subheading of the HADS.

Conclusions

BETY-BQ is as a valid and reliable instrument by which, multidisciplinary-interdisciplinary healthcare teams can evaluate the biopsychosocial features among PLWH in a holistic and practical manner. Preliminary findings also suggest its potential sensitivity to change, particularly concerning depressive symptoms; however, further studies are needed to establish its responsiveness fully.

Clinical trial number

Not applicable.